Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

altRX vs Zera Health

altRX
Graded #92

Lower grade

vs+3.3999999999999915
Zera Health
Graded #63

Higher grade

The verdict

Zera Health takes it — 74.8/100 to 71.4/100.

Zera Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Zera Health is a telehealth platform for compounded GLP-1 weight loss — semaglutide from $149/mo, tirzepatide from $199/mo, plus oral and low-dose microdose options — prescribed by licensed physicians in…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueZera Health +6
74
80
Dose & formulationaltRX +2
77
75
Clinical oversightEven
82
82
Labs & monitoringEven
53
53
FulfillmentZera Health +19
73
92
Contract termsEven
55
55
altRX · left barZera Health · right bar

The numbers

MetricaltRXZera Health
WeighScore71.4/10074.8/100
GradeCC
Scorecard rank#92#63
Semaglutide$149/mo (starting dose, compounded)$149/mo (compounded)
Tirzepatide$249/mo (starting dose, compounded)$199/mo (compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
altRX

Graded #92 · C

Strengths

  • Offers all four brand-name FDA-approved GLP-1s (Mounjaro, Ozempic, Wegovy, Zepbound) — the most comprehensive brand-name access we've reviewed
  • LegitScript Certified with a publicly verifiable seal
  • Publishes the FDA compounded-medication disclaimer
  • Transparent pricing across all six product tiers (compounded plus four brand-name)
  • All-inclusive pricing — consult, prescription, and shipping with no hidden fees

Where it loses points

  • States-served list not disclosed
  • 503A/503B pharmacy partner not named (only 'multiple USA-certified pharmacies')
  • 503A vs 503B designation not specified
  • No named medical director
  • Corporate physical address not disclosed
Zera Health

Graded #63 · C

Strengths

  • Compounded semaglutide from $149/mo and tirzepatide from $199/mo, plus a $129/mo microdose option
  • Flat pricing — the same monthly cost at every dose as you titrate up
  • All-inclusive: medication, unlimited 24/7 provider messaging, and free shipping bundled in
  • Names its compounding pharmacy — Strive Pharmacy (licensed 503A)
  • Available in all 50 states with same-day approvals

Where it loses points

  • Operates as a technology platform, not the medical provider itself
  • Compounded GLP-1s are not FDA-approved (the site discloses this honestly)
  • Aggressive marketing results claims (e.g. '18% average', '93% kept it off') with 'results not typical' disclaimers
  • Legal entity name not published (footer shows only 'Zera Health')

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard